Search research articles
Contact Us
Filters
Showing results (61-70 of 242) with videos related to
Page
of 25
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2008
Cisplatin-resistant neuroblastoma cells express enhanced levels of epidermal growth factor receptor (EGFR) and are sensitive to treatment with EGFR-specific toxins
Martin Michaelis, Jennifer Bliss, Sonja C Arnold, et al.
Pharmacological Research
|
December 1, 2021
iTReX: Interactive exploration of mono- and combination therapy dose response profiling data
Dina ElHarouni, Yannick Berker, Heike Peterziel, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 30, 2020
Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish Xenografts
Jagoda K Wrobel, Sara Najafi, Simay Ayhan, et al.
International Journal of Cancer
|
June 25, 2020
Loss of efficacy of subsequent nonsurgical therapy after primary treatment failure in pediatric low-grade glioma patients-Report from the German SIOP-LGG 2004 cohort
Daniela Kandels, Torsten Pietsch, Brigitte Bison, et al.
Archives of Toxicology
|
June 28, 2018
The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines
Fiona R Kolbinger, Emily Koeneke, Johannes Ridinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 24, 2010
HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth
Till Milde, Ina Oehme, Andrey Korshunov, et al.
BMC Neurology
|
August 10, 2016
EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex
Andras Fogarasi, Liesbeth De Waele, Gabriella Bartalini, et al.
Biochemical Pharmacology
|
August 25, 2009
Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines
Martin Michaelis, Malte C Kleinschmidt, Susanne Barth, et al.
Cell Death & Disease
|
August 25, 2017
Three-dimensional tumor cell growth stimulates autophagic flux and recapitulates chemotherapy resistance
Corinna Bingel, Emily Koeneke, Johannes Ridinger, et al.
Cell Death & Disease
|
March 3, 2017
Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival
Theresa M Thole, Marco Lodrini, Johannes Fabian, et al.
Page
of 25
Search research articles
Search
Showing results (61-70 of 242) with videos related to
Sort By:
Page
of 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2008
Cisplatin-resistant neuroblastoma cells express enhanced levels of epidermal growth factor receptor (EGFR) and are sensitive to treatment with EGFR-specific toxins
Martin Michaelis, Jennifer Bliss, Sonja C Arnold, et al.
Pharmacological Research
|
December 1, 2021
iTReX: Interactive exploration of mono- and combination therapy dose response profiling data
Dina ElHarouni, Yannick Berker, Heike Peterziel, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 30, 2020
Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish Xenografts
Jagoda K Wrobel, Sara Najafi, Simay Ayhan, et al.
International Journal of Cancer
|
June 25, 2020
Loss of efficacy of subsequent nonsurgical therapy after primary treatment failure in pediatric low-grade glioma patients-Report from the German SIOP-LGG 2004 cohort
Daniela Kandels, Torsten Pietsch, Brigitte Bison, et al.
Archives of Toxicology
|
June 28, 2018
The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines
Fiona R Kolbinger, Emily Koeneke, Johannes Ridinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 24, 2010
HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth
Till Milde, Ina Oehme, Andrey Korshunov, et al.
BMC Neurology
|
August 10, 2016
EFFECTS: an expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex
Andras Fogarasi, Liesbeth De Waele, Gabriella Bartalini, et al.
Biochemical Pharmacology
|
August 25, 2009
Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines
Martin Michaelis, Malte C Kleinschmidt, Susanne Barth, et al.
Cell Death & Disease
|
August 25, 2017
Three-dimensional tumor cell growth stimulates autophagic flux and recapitulates chemotherapy resistance
Corinna Bingel, Emily Koeneke, Johannes Ridinger, et al.
Cell Death & Disease
|
March 3, 2017
Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival
Theresa M Thole, Marco Lodrini, Johannes Fabian, et al.
Page
of 25